Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$513,681
+$30,649 QoQ
Shares Held
55,057
+14.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Graham Capital Management, L.P. holds $4,664,055 across 12 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
75,653 | $1,212,717 | |
| 2 | HLN |
Haleon plc
This page
|
55,057 | $513,681 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
101,971 | $502,717 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
24,035 | $416,045 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
7,136 | $337,318 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
8,555 | $309,691 | |
| 7 | ZTS |
Zoetis Inc.
|
4,304 | $309,285 | |
| 8 | PRGO |
PERRIGO Co plc
|
28,290 | $293,933 |
All Filings in HLN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $513,681 | 55,057 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $483,032 | 48,255 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $972,529 | 93,783 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $226,235 | 21,986 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||